El Camino Hospital's board just got bigger. In a move intended to help the hospital board make better decisions, the health care organization finalized the appointment of three new directors on June 7.
Dr. Neal H. Cohen, Dr. Jeffrey Davis and Nandini Tandon -- all of whom have experience in medicine and business -- will help the hospital board "apply governance best practices" and "create more depth of subject matter expertise in the areas of finance, quality and policy," according to an El Camino press release.
All three new board members -- who will join the hospital board but not the hospital district board -- boast lengthy and diverse resumes.
Cohen is a medical doctor with multiple master's degrees in business and public health has experience in risk management and regulatory affairs; he is currently working as a professor of anesthesia and perioperative care and medicine at the U.C. San Francisco School of Medicine.
Davis is also a medical doctor with a master's degree in public health. He is the chief medical officer of Avivia Health -- a wholly-owned subsidiary of Kaiser Permanente -- and the medical director of national sales and account management at Kaiser.
Tandon holds a doctoral degree in biochemistry. She has 20 years experience serving on the boards of pharmaceutical and biotechnology firms and worked as a venture capitalist in Silicon Valley for a decade.
"Drs. Cohen, Davis and Tandon bring years of clinical and business expertise that will further strengthen the board's expertise -- not just in finance, quality and policy -- but also add a new dimension to our knowledge in hospital and physician relations, managed care, population health and disease management," said El Camino Hospital District Board Chairman, John Zoglin, in a statement. "Beyond these areas, their understanding of the dynamic health care market in Northern California will help us continue providing high-quality care for our patients in a rapidly changing health care environment."